Qiming Venture Partners VI, L.P. 的 Form 4 申報

Alamar Biosciences, Inc.ALMR，2026/11/3 申報

申報編號: 0001231919-26-001531
申報時間: 2026/11/3 16:15 ET
交易日: 2026/10/30-11/2
申報延遲: 4 天
10b5-1 計畫: 沒有勾選

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 24 筆非衍生性交易。公開市場賣出合計 $567.6 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Qiming Venture Partners VI, L.P.CIK 0001733278	持股 10% 以上大股東
Qiming Managing Directors Fund VI, L.P.CIK 0001733282	持股 10% 以上大股東
Qiming Venture Partners VIII-HC, L.P.CIK 0001910025	持股 10% 以上大股東
Qiming Corporate GP VI, Ltd.CIK 0002059127	持股 10% 以上大股東
Qiming Venture Partners VIII Investments, LLCCIK 0002129618	持股 10% 以上大股東
Qiming GP VIII-HC, LLCCIK 0002129671	持股 10% 以上大股東
Qiming GP VIII, LLCCIK 0002129740	持股 10% 以上大股東

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2026/10/30	Common Stock	S賣出處分	−1,309	$29.93^F1	−$39,178.37	162,882	間接
2026/10/30	Common Stock	S賣出處分	−1,080	$30.70^F3	−$33,156	161,802	間接
2026/10/30	Common Stock	S賣出處分	−92	$31.96^F4	−$2,940.32	161,710	間接
2026/10/30	Common Stock	S賣出處分	−31	$33.31^F5	−$1,032.61	161,679	間接
2026/10/30	Common Stock	S賣出處分	−48,659	$29.93^F1	−$1,456,363.87	6,053,320	間接
2026/10/30	Common Stock	S賣出處分	−40,112	$30.70^F3	−$1,231,438.4	6,013,208	間接
2026/10/30	Common Stock	S賣出處分	−3,400	$31.96^F4	−$108,664	6,009,808	間接
2026/10/30	Common Stock	S賣出處分	−1,169	$33.31^F5	−$38,939.39	6,008,639	間接
2026/10/30	Common Stock	S賣出處分	−11,354	$29.93^F1	−$339,825.22	1,412,427	間接
2026/10/30	Common Stock	S賣出處分	−9,359	$30.70^F3	−$287,321.3	1,403,068	間接
2026/10/30	Common Stock	S賣出處分	−793	$31.96^F4	−$25,344.28	1,402,275	間接
2026/10/30	Common Stock	S賣出處分	−273	$33.31^F5	−$9,093.63	1,402,002	間接
2026/10/30	Common Stock	S賣出處分	−13,593	$29.93^F1	−$406,838.49	1,691,003	間接
2026/10/30	Common Stock	S賣出處分	−11,205	$30.70^F3	−$343,993.5	1,679,798	間接
2026/10/30	Common Stock	S賣出處分	−950	$31.96^F4	−$30,362	1,678,848	間接
2026/10/30	Common Stock	S賣出處分	−327	$33.31^F5	−$10,892.37	1,678,521	間接
2026/11/2	Common Stock	S賣出處分	−763	$29.84^F9	−$22,767.92	160,916	間接
2026/11/2	Common Stock	S賣出處分	−3	$30.63	−$91.89	160,913	間接
2026/11/2	Common Stock	S賣出處分	−28,404	$29.84^F9	−$847,575.36	5,980,235	間接
2026/11/2	Common Stock	S賣出處分	−131	$30.63	−$4,012.53	5,980,104	間接
2026/11/2	Common Stock	S賣出處分	−6,628	$29.84^F9	−$197,779.52	1,395,374	間接
2026/11/2	Common Stock	S賣出處分	−30	$30.63	−$918.9	1,395,344	間接
2026/11/2	Common Stock	S賣出處分	−7,935	$29.84^F9	−$236,780.4	1,670,586	間接
2026/11/2	Common Stock	S賣出處分	−36	$30.63	−$1,102.68	1,670,550	間接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.49, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (5) and (9) to this Form 4.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.50 to $31.46, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.52 to $32.465, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.68 to $33.59, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.44, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文（在新分頁開啟）